financetom
Business
financetom
/
Business
/
Aurora Innovation Insider Sold Shares Worth $27,455,944, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aurora Innovation Insider Sold Shares Worth $27,455,944, According to a Recent SEC Filing
Nov 9, 2024 1:35 PM

05:25 PM EST, 11/08/2024 (MT Newswires) -- Reid Hoffman, Director, on November 06, 2024, sold 4,929,713 shares in Aurora Innovation ( AUR ) for $27,455,944. Following the Form 4 filing with the SEC, Hoffman has control over a total of 9,154,991 shares of the company, with 286,247 shares held directly and 8,868,744 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1828108/000182810824000145/xslF345X05/wk-form4_1731103992.xml

Price: 5.19, Change: +0.01, Percent Change: +0.19

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gatos Silver Reports 2024 Production at the Top End of Guidance
Gatos Silver Reports 2024 Production at the Top End of Guidance
Jan 9, 2025
04:24 PM EST, 01/09/2025 (MT Newswires) -- Gatos Silver ( GATO ) after close of trade Thursday reported 2024 production for its 70%-owned Cerro Los Gatos (CLG) mine in Mexico. Silver production was at the top end of the 2024 guidance range and silver equivalent production was slightly above the top end of the 2024 guidance range, according to the...
Aptose Biosciences Initiates Dosing in Early Study of Acute Myeloid Leukemia Treatment
Aptose Biosciences Initiates Dosing in Early Study of Acute Myeloid Leukemia Treatment
Jan 9, 2025
04:26 PM EST, 01/09/2025 (MT Newswires) -- Aptose Biosciences ( APTO ) dosed the first set of patients in the phase 1/2 study of tuspetinib in combination with venetoclax and azacitidine in patients newly diagnosed with acute myeloid leukemia. Patient enrollment is expected to be 18 to 24 in mid- to late 2025, the company said Thursday in a statement....
Boeing donating $1 million to Trump presidential inaugural fund, spokesperson says
Boeing donating $1 million to Trump presidential inaugural fund, spokesperson says
Jan 9, 2025
WASHINGTON (Reuters) - Boeing is donating $1 million to U.S. President-elect Donald Trump's inauguration, a spokesperson for the U.S. planemaker said on Thursday. Boeing is joining many major U.S. companies including General Motors, Ford, Microsoft and Meta in donating for the Jan. 20 event. The planemaker previously donated $1 million to the last three presidential inaugurations, including Trump's first in...
IO Biotech Completes Enrollment in Phase 2 Trial of Cancer Vaccine to Treat Resectable Melanoma
IO Biotech Completes Enrollment in Phase 2 Trial of Cancer Vaccine to Treat Resectable Melanoma
Jan 9, 2025
04:24 PM EST, 01/09/2025 (MT Newswires) -- IO Biotech ( IOBT ) said Thursday it completed enrollment ahead of schedule in a phase 2 trial of its cancer vaccine candidate IO102-IO103 combined with Merck's ( MRK ) Keytruda to treat people with resectable melanoma or squamous cell carcinoma of the head and neck. Initial data is expected this year, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved